-
公开(公告)号:US09969752B2
公开(公告)日:2018-05-15
申请号:US15514536
申请日:2015-09-23
发明人: Jiaqiang Cai , Alejandro Crespo , Xiaoxing Du , Byron Gabriel Dubois , Deodialsingh Guiadeen , Shankaran Kothandaraman , Ping Liu , Rongqiang Liu , Weiguo Quan , Christopher Sinz , Liping Wang
IPC分类号: C07D471/06 , C07D498/06 , C07D513/06 , C07D498/16
CPC分类号: C07D513/06 , C07D471/04 , C07D471/06 , C07D498/04 , C07D498/06 , C07D498/16 , C07D513/04
摘要: The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.